Is AMD Stock an All-Time Buy?
Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…
Sell
31
IHF Quote, Financials, Valuation and Earnings
Last price:
$48.27
Seasonality move
:
0.29%
Day range:
$48.29 - $48.76
52-week range:
$47.21 - $58.94
Dividend yield:
0.85%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
80.7K
Avg. volume:
99.7K
1-year change:
-7.13%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
IHF
iShares US Healthcare Providers ETF
|
-- | -- | -- | -- | -- |
|
BBH
VanEck Biotech ETF
|
-- | -- | -- | -- | -- |
|
FTXH
First Trust Nasdaq Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
|
IHE
iShares US Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
IHF
iShares US Healthcare Providers ETF
|
$48.68 | -- | -- | -- | $0.10 | 0.85% | -- |
|
BBH
VanEck Biotech ETF
|
$159.19 | -- | -- | -- | $1.25 | 0.79% | -- |
|
FTXH
First Trust Nasdaq Pharmaceuticals ETF
|
$27.39 | -- | -- | -- | $0.13 | 1.64% | -- |
|
IHE
iShares US Pharmaceuticals ETF
|
$66.82 | -- | -- | -- | $0.21 | 1.7% | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
$83.65 | -- | -- | -- | $0.22 | 0.96% | -- |
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
$29.70 | -- | -- | -- | $0.06 | 0.7% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
IHF
iShares US Healthcare Providers ETF
|
-- | 1.288 | -- | -- |
|
BBH
VanEck Biotech ETF
|
-- | 1.127 | -- | -- |
|
FTXH
First Trust Nasdaq Pharmaceuticals ETF
|
-- | 1.073 | -- | -- |
|
IHE
iShares US Pharmaceuticals ETF
|
-- | 1.040 | -- | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
-- | 0.832 | -- | -- |
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
-- | 1.335 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
IHF
iShares US Healthcare Providers ETF
|
-- | -- | -- | -- | -- | -- |
|
BBH
VanEck Biotech ETF
|
-- | -- | -- | -- | -- | -- |
|
FTXH
First Trust Nasdaq Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
|
IHE
iShares US Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
-- | -- | -- | -- | -- | -- |
iShares US Healthcare Providers ETF vs. Competitors
-
Which has Higher Returns IHF or BBH?
VanEck Biotech ETF has a net margin of -- compared to iShares US Healthcare Providers ETF's net margin of --. iShares US Healthcare Providers ETF's return on equity of -- beat VanEck Biotech ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IHFiShares US Healthcare Providers ETF-- -- -- BBHVanEck Biotech ETF-- -- -- -
What do Analysts Say About IHF or BBH?
iShares US Healthcare Providers ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand VanEck Biotech ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Healthcare Providers ETF has higher upside potential than VanEck Biotech ETF, analysts believe iShares US Healthcare Providers ETF is more attractive than VanEck Biotech ETF.
Company Buy Ratings Hold Ratings Sell Ratings IHFiShares US Healthcare Providers ETF0 0 0 BBHVanEck Biotech ETF0 0 0 -
Is IHF or BBH More Risky?
iShares US Healthcare Providers ETF has a beta of 0.765, which suggesting that the stock is 23.516% less volatile than S&P 500. In comparison VanEck Biotech ETF has a beta of 0.727, suggesting its less volatile than the S&P 500 by 27.303%.
-
Which is a Better Dividend Stock IHF or BBH?
iShares US Healthcare Providers ETF has a quarterly dividend of $0.10 per share corresponding to a yield of 0.85%. VanEck Biotech ETF offers a yield of 0.79% to investors and pays a quarterly dividend of $1.25 per share. iShares US Healthcare Providers ETF pays -- of its earnings as a dividend. VanEck Biotech ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IHF or BBH?
iShares US Healthcare Providers ETF quarterly revenues are --, which are smaller than VanEck Biotech ETF quarterly revenues of --. iShares US Healthcare Providers ETF's net income of -- is lower than VanEck Biotech ETF's net income of --. Notably, iShares US Healthcare Providers ETF's price-to-earnings ratio is -- while VanEck Biotech ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Healthcare Providers ETF is -- versus -- for VanEck Biotech ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IHFiShares US Healthcare Providers ETF-- -- -- -- BBHVanEck Biotech ETF-- -- -- --
-
Which has Higher Returns IHF or FTXH?
First Trust Nasdaq Pharmaceuticals ETF has a net margin of -- compared to iShares US Healthcare Providers ETF's net margin of --. iShares US Healthcare Providers ETF's return on equity of -- beat First Trust Nasdaq Pharmaceuticals ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IHFiShares US Healthcare Providers ETF-- -- -- FTXHFirst Trust Nasdaq Pharmaceuticals ETF-- -- -- -
What do Analysts Say About IHF or FTXH?
iShares US Healthcare Providers ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust Nasdaq Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Healthcare Providers ETF has higher upside potential than First Trust Nasdaq Pharmaceuticals ETF, analysts believe iShares US Healthcare Providers ETF is more attractive than First Trust Nasdaq Pharmaceuticals ETF.
Company Buy Ratings Hold Ratings Sell Ratings IHFiShares US Healthcare Providers ETF0 0 0 FTXHFirst Trust Nasdaq Pharmaceuticals ETF0 0 0 -
Is IHF or FTXH More Risky?
iShares US Healthcare Providers ETF has a beta of 0.765, which suggesting that the stock is 23.516% less volatile than S&P 500. In comparison First Trust Nasdaq Pharmaceuticals ETF has a beta of 0.658, suggesting its less volatile than the S&P 500 by 34.157%.
-
Which is a Better Dividend Stock IHF or FTXH?
iShares US Healthcare Providers ETF has a quarterly dividend of $0.10 per share corresponding to a yield of 0.85%. First Trust Nasdaq Pharmaceuticals ETF offers a yield of 1.64% to investors and pays a quarterly dividend of $0.13 per share. iShares US Healthcare Providers ETF pays -- of its earnings as a dividend. First Trust Nasdaq Pharmaceuticals ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IHF or FTXH?
iShares US Healthcare Providers ETF quarterly revenues are --, which are smaller than First Trust Nasdaq Pharmaceuticals ETF quarterly revenues of --. iShares US Healthcare Providers ETF's net income of -- is lower than First Trust Nasdaq Pharmaceuticals ETF's net income of --. Notably, iShares US Healthcare Providers ETF's price-to-earnings ratio is -- while First Trust Nasdaq Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Healthcare Providers ETF is -- versus -- for First Trust Nasdaq Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IHFiShares US Healthcare Providers ETF-- -- -- -- FTXHFirst Trust Nasdaq Pharmaceuticals ETF-- -- -- --
-
Which has Higher Returns IHF or IHE?
iShares US Pharmaceuticals ETF has a net margin of -- compared to iShares US Healthcare Providers ETF's net margin of --. iShares US Healthcare Providers ETF's return on equity of -- beat iShares US Pharmaceuticals ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IHFiShares US Healthcare Providers ETF-- -- -- IHEiShares US Pharmaceuticals ETF-- -- -- -
What do Analysts Say About IHF or IHE?
iShares US Healthcare Providers ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Healthcare Providers ETF has higher upside potential than iShares US Pharmaceuticals ETF, analysts believe iShares US Healthcare Providers ETF is more attractive than iShares US Pharmaceuticals ETF.
Company Buy Ratings Hold Ratings Sell Ratings IHFiShares US Healthcare Providers ETF0 0 0 IHEiShares US Pharmaceuticals ETF0 0 0 -
Is IHF or IHE More Risky?
iShares US Healthcare Providers ETF has a beta of 0.765, which suggesting that the stock is 23.516% less volatile than S&P 500. In comparison iShares US Pharmaceuticals ETF has a beta of 0.656, suggesting its less volatile than the S&P 500 by 34.431%.
-
Which is a Better Dividend Stock IHF or IHE?
iShares US Healthcare Providers ETF has a quarterly dividend of $0.10 per share corresponding to a yield of 0.85%. iShares US Pharmaceuticals ETF offers a yield of 1.7% to investors and pays a quarterly dividend of $0.21 per share. iShares US Healthcare Providers ETF pays -- of its earnings as a dividend. iShares US Pharmaceuticals ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IHF or IHE?
iShares US Healthcare Providers ETF quarterly revenues are --, which are smaller than iShares US Pharmaceuticals ETF quarterly revenues of --. iShares US Healthcare Providers ETF's net income of -- is lower than iShares US Pharmaceuticals ETF's net income of --. Notably, iShares US Healthcare Providers ETF's price-to-earnings ratio is -- while iShares US Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Healthcare Providers ETF is -- versus -- for iShares US Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IHFiShares US Healthcare Providers ETF-- -- -- -- IHEiShares US Pharmaceuticals ETF-- -- -- --
-
Which has Higher Returns IHF or PJP?
Invesco Pharmaceuticals ETF has a net margin of -- compared to iShares US Healthcare Providers ETF's net margin of --. iShares US Healthcare Providers ETF's return on equity of -- beat Invesco Pharmaceuticals ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IHFiShares US Healthcare Providers ETF-- -- -- PJPInvesco Pharmaceuticals ETF-- -- -- -
What do Analysts Say About IHF or PJP?
iShares US Healthcare Providers ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Healthcare Providers ETF has higher upside potential than Invesco Pharmaceuticals ETF, analysts believe iShares US Healthcare Providers ETF is more attractive than Invesco Pharmaceuticals ETF.
Company Buy Ratings Hold Ratings Sell Ratings IHFiShares US Healthcare Providers ETF0 0 0 PJPInvesco Pharmaceuticals ETF0 0 0 -
Is IHF or PJP More Risky?
iShares US Healthcare Providers ETF has a beta of 0.765, which suggesting that the stock is 23.516% less volatile than S&P 500. In comparison Invesco Pharmaceuticals ETF has a beta of 0.580, suggesting its less volatile than the S&P 500 by 42.037%.
-
Which is a Better Dividend Stock IHF or PJP?
iShares US Healthcare Providers ETF has a quarterly dividend of $0.10 per share corresponding to a yield of 0.85%. Invesco Pharmaceuticals ETF offers a yield of 0.96% to investors and pays a quarterly dividend of $0.22 per share. iShares US Healthcare Providers ETF pays -- of its earnings as a dividend. Invesco Pharmaceuticals ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IHF or PJP?
iShares US Healthcare Providers ETF quarterly revenues are --, which are smaller than Invesco Pharmaceuticals ETF quarterly revenues of --. iShares US Healthcare Providers ETF's net income of -- is lower than Invesco Pharmaceuticals ETF's net income of --. Notably, iShares US Healthcare Providers ETF's price-to-earnings ratio is -- while Invesco Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Healthcare Providers ETF is -- versus -- for Invesco Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IHFiShares US Healthcare Providers ETF-- -- -- -- PJPInvesco Pharmaceuticals ETF-- -- -- --
-
Which has Higher Returns IHF or RSPH?
Invesco S&P 500 Eql Wght Health Care ETF has a net margin of -- compared to iShares US Healthcare Providers ETF's net margin of --. iShares US Healthcare Providers ETF's return on equity of -- beat Invesco S&P 500 Eql Wght Health Care ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IHFiShares US Healthcare Providers ETF-- -- -- RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- -
What do Analysts Say About IHF or RSPH?
iShares US Healthcare Providers ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco S&P 500 Eql Wght Health Care ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Healthcare Providers ETF has higher upside potential than Invesco S&P 500 Eql Wght Health Care ETF, analysts believe iShares US Healthcare Providers ETF is more attractive than Invesco S&P 500 Eql Wght Health Care ETF.
Company Buy Ratings Hold Ratings Sell Ratings IHFiShares US Healthcare Providers ETF0 0 0 RSPHInvesco S&P 500 Eql Wght Health Care ETF0 0 0 -
Is IHF or RSPH More Risky?
iShares US Healthcare Providers ETF has a beta of 0.765, which suggesting that the stock is 23.516% less volatile than S&P 500. In comparison Invesco S&P 500 Eql Wght Health Care ETF has a beta of 0.863, suggesting its less volatile than the S&P 500 by 13.707%.
-
Which is a Better Dividend Stock IHF or RSPH?
iShares US Healthcare Providers ETF has a quarterly dividend of $0.10 per share corresponding to a yield of 0.85%. Invesco S&P 500 Eql Wght Health Care ETF offers a yield of 0.7% to investors and pays a quarterly dividend of $0.06 per share. iShares US Healthcare Providers ETF pays -- of its earnings as a dividend. Invesco S&P 500 Eql Wght Health Care ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IHF or RSPH?
iShares US Healthcare Providers ETF quarterly revenues are --, which are smaller than Invesco S&P 500 Eql Wght Health Care ETF quarterly revenues of --. iShares US Healthcare Providers ETF's net income of -- is lower than Invesco S&P 500 Eql Wght Health Care ETF's net income of --. Notably, iShares US Healthcare Providers ETF's price-to-earnings ratio is -- while Invesco S&P 500 Eql Wght Health Care ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Healthcare Providers ETF is -- versus -- for Invesco S&P 500 Eql Wght Health Care ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IHFiShares US Healthcare Providers ETF-- -- -- -- RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 43x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
57
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
64
ARQQ alert for Dec 27
Arqit Quantum [ARQQ] is down 6.68% over the past day.
Buy
64
QMCO alert for Dec 27
Quantum [QMCO] is down 1.14% over the past day.
Buy
65
ALGS alert for Dec 27
Aligos Therapeutics [ALGS] is down 3.16% over the past day.
